Human papillomavirus: Burden of illness and treatment cost considerations

American Journal of Clinical Dermatology

Volumn 6, Issue 6, 2005, Pages 365-381

  Fox, Paul A ^a,b   Tung, Mun Yee ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b EALING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALPHA INTERFERON; ALPHA2B INTERFERON; BLEOMYCIN; CIDOFOVIR; CIMETIDINE; DIPHENCYPRONE; FLUOROURACIL; FORMALDEHYDE; GLUTARALDEHYDE; IMIQUIMOD; METHISOPRINOL; PODOPHYLLIN; PODOPHYLLOTOXIN; SALICYLIC ACID; TRICHLOROACETIC ACID; WART VIRUS VACCINE;

ANAL INTRAEPITHELIAL NEOPLASIA; ANUS; BONE MARROW DEPRESSION; BOWENOID PAPULOSIS; BURNING SENSATION; CARBON DIOXIDE LASER; CLINICAL TRIAL; COMA; CONDYLOMA; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DRUG FATALITY; EDEMA; ELECTROSURGERY; ERYTHEMA; EXCISION; EXTRAGENITAL WART; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERPIGMENTATION; HYPOPIGMENTATION; KIDNEY FAILURE; LASER SURGERY; LOCAL SKIN REACTION; LUNG FIBROSIS; LYMPHANGITIS; MEDLINE; MORBIDITY; MUTAGENICITY; NEOPLASM; NONHUMAN; PAIN; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; RESPIRATION DEPRESSION; REVIEW; SCAR FORMATION; SKIN EROSION; SKIN IRRITATION; SKIN ULCER; SWELLING; SYSTEMIC CIRCULATION; TOXICITY; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; VIRUS INFECTION; VOMITING; VULVA INTRAEPITHELIAL NEOPLASIA; WART VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CRYOTHERAPY; ELECTROSURGERY; FEMALE; HUMANS; KERATOLYTIC AGENTS; LASER SURGERY; NEOPLASMS; PAPILLOMAVIRIDAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL VACCINES; WARTS;

EID: 31144473869     PISSN: 11750561     EISSN: 11750561     Source Type: Journal    
DOI: 10.2165/00128071-200506060-00004     Document Type: Review

References (136)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102 (5a): 3-8
2. Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997; 102 (5a): 9-15
3. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999; 9 (6): 423-30
4. Fu Xi L, Carter JJ, Galloway DA, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 2002; 11: 343-51
5. Van Doornum GJJ, Prins M, Juffermans LHJ, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 1994; 70 (4): 240-6
6. Grussendorf-Conen EI, Jacobs S, Rubben A, et al. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities. Dermatology 2002; 205 (2): 139-45
7. Leman JA, Benton EC. Verrucas: guidelines for management. Am J Clin Dermatol 2000; 1 (3): 143-9
8. Wilson JD, Brown CB, Walker PP. Factors involved in clearance of genital warts. Int J STD AIDS 2001; 12 (12): 789-92
9. Reichman RC, Oakes D, Bonnez W, et al. Treatment of condylomata accuminata with 3 different interferon alpha preparations administered parenterally: a double blind placebo controlled trial. J Infect Dis 1990; 162: 1270-6
10. Douglas Jr JM, Eron LJ, Judson FN, et al. A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. J Infect Dis 1990; 162 (1): 52-9
11. Mohanty KC, Scott CS. Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study. Genitourin Med 1986; 62 (5): 352-5
12. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997; 102 (5A): 28-37
13. Zhu WY, Blauvelt A, Goldstein BA, et al. Detection with the polymerase chain reaction of human papillomavirus DNA in condylomata acuminata treated in vitro with liquid nitrogen, trichloroacetic acid, and podophyllin. J Am Acad Dermatol 1992; 26 (5 Pt 1): 710-4
14. Connolly M, Bazmi K, O'Connell M, et al. Cryotherapy of viral warts, a sustained 10s freeze is more effective than the traditional method. Br J Dermatol 2001; 145: 554-7
15. Sonnex TS, Camp RDR. The treatment of recalcitrant viral warts with high dose cryosurgery under local anaesthesia. Br J Dermatol 1988; 119 Suppl. 33: 38-9
16. Clinical Effectiveness Group. National guidelines for the management of anogenital warts. Sex Transm Inf 1999; 75 Suppl. 1: S71-5
17. Berth-Jones J, Bourke J, Eglitis H, et al. Value of second freeze-thaw cycle in cryotherapy of common warts. Br J Dermatol 1994; 131: 883-6
18. Wallin J. 5-Fluorouracil in the treatment of penile and urethral condylomata acuminata. Br J Vener Dis 1977; 53 (4): 240-3
19. Simmons PD, Langlet F, Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis 1981; 57 (4): 273-4
20. Stone KM, Becker TM, Hadgu A, et al. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 1990; 66 (1): 16-9
21. 2 laser ablation. J Gynecol Surg 1995; 11 (1): 41-50
22. Duus BR, Philipsen T, Christensen JD, et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 1985; 61 (1): 59-61
23. Bar-Am A, Shilon M, Peyser MR, et al. Treatment of male genital condylomatous lesions by carbon dioxide laser after failure of previous nonlaser methods. J Am Acad Dermatol 1991; 24 (1): 87-9
24. Ammori BJ, Ausobsky JR. Electrocoagulation of perianal warts: a word of caution. Dig Surg 2000; 17 (3): 296-7
25. Bellina JH. The use of the carbon dioxide laser in the management of condyloma acuminatum with eight-year follow-up. Am J Obstet Gynecol 1983; 147 (4): 375-8
26. Hallmo P, Naess O. Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol 1991; 248 (7): 425-7
27. Garden JM, O'Banion MK, Bakus AD, et al. Viral disease transmitted by laser-generated plume (aerosol). Arch Dermatol 2002; 138 (10): 1303-7
28. Thomson JPS, Grace RH. The treatment of perianal and anal condylomata: a new operative technique. J R Soc Med 1978; 71: 180-5
29. Jensen SL. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata. Lancet 1985; II (8465): 1146-8
30. Khawaja HT. Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study. Br J Surg 1989; 76 (10): 1067-8
31. Orlow SJ, Paller A. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol 1993; 28: 794-6
32. Glass AT, Solomon BA. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol 1996; 132: 680-2
33. Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol 1996; 34 (6): 1005-7
34. Davidson-Parker J, Dinsmore W, Khan MH, et al. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study. Genitourin Med 1988; 64 (6): 383-6
35. Tay SK. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study. Int J STD AIDS 1996; 7 (4): 276-80
36. Benton EC, Nolan MW, Kemmett D, et al. A trial of inosine pranobex in the management of cutaneous viral warts. J Dermatolog Treat 1991; 1 (6): 295-7
37. Syed TA, Cheema KM, Khayyami M, et al. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males: a placebo-controlled, double-blind, comparative study. Dermatol 1995; 191 (2): 129-32
38. Syed TA, Khayyami M, Kriz D, et al. Management of genital warts in women with human leukocyte interferon-alpha vs podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study. J Mol Med 1995; 73 (5): 255-8
39. Armstrong DK, Maw RD, Dinsmore WW, et al. A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata. Genitourin Med 1994; 70 (6): 389-93
40. Syed TA, Hadi SM, Qureshi ZA, et al. Treatment of external genital warts in men with imiquimod 2% in cream: a placebo-controlled, double-blind study. J Infect 2000; 41 (2): 148-51
41. Stanley MA. Mechanism of action of imiquimod. Papillomavirus Rep 1999; 10: 23-9
42. Skinner Jr RB. Imiquimod. Dermatol Clin 2003; 21 (2): 291-300
43. Garland SM, Sellors JW, Wikstrom A, et al. Imiquimod 5% cream is safe and effective self applied treatment for anogenital warts: results of an open label multicentre phase IIIB trial. Int J STD AIDS 2001; 12 (11): 722-9
44. Garland SM. Imiquimod. Curr Opin Infect Dis 2003; 16 (2): 85-9
45. Fife KH, Ferenczy A, Douglas Jr JM, et al. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis 2001; 28 (4): 226-31
46. Sauder DN, Skinner RB, Fox TL, et al. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis 2003; 30 (2): 124-8
47. Williams P, von Krogh G. The cost-effectiveness of patient-applied treatments for anogenital warts. Int J STD AIDS 2003; 14 (4): 228-34
48. Gollnick H, Barasso R, Jappe U, et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12 (1): 22-8
49. Moore RA, Edwards JE, Hopwood J, et al. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001; 1 (1): 3
50. O'Mahony C, Law C, Gollnick HPM, et al. New patient applied therapy for anogenital warts is rated favourably by patients. Int J STD AIDS 2001; 12 (9): 565-70
51. Vilata JJ, Badia X. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts. Int J STD AIDS 2003; 14 (1): 11-7
52. Gibbs S, Harvey I, Sterling JC, et al. Local treatments for cutaneous warts. Cochrane Database Syst Rev 2003; (3): CD001781
53. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143 (5): 1026-31
54. Muzio G, Massone C, Rebora A. Treatment of non-genital warts with topical imiquimod 5% cream. Eur J Dermatol 2002; 12 (4): 347-9
55. Tucker SB, Ali A, Ransdell BL. Plantar wart treatment with combination imiquimod and salicylic acid pads. J Drugs Dermatol 2003; 2 (2): 124-6
56. Atzori L, Pinna AL, Ferreli C. Extensive and recalcitrant verrucae vulgaris of the great toe treated with imiquimod 5% cream. J Eur Acad Dermatol Venereol 2003; 17 (3): 366-7
57. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol 2002; 19 (3): 263-6
58. Kaspari M, Gutzmer R, Kaspari T, et al. Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma. Br J Dermatol 2002; 147 (4): 757-9
59. Hoyme UB, Hagedorn M, Schindler AE, et al. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment. Infect Dis Obstet Gynecol 2002; 10 (2): 79-88
60. Carrasco D, vander Straten M, Tyring SK. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions. J Am Acad Dermatol 2002; 47 (4 Suppl.): S212-6
61. Schwartz DB, Greenberg MD, Daoud Y, et al. Genital condylomas in pregnancy: use of trichloroacetic acid and laser therapy. Am J Obstet Gynecol 1988; 158 (6 Pt 1): 1407-16
62. Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloroacetic acid. Sex Transm Dis 1993; 20 (6): 344-5
63. Godley MJ, Bradbeer CS, Gellan M, et al. Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med 1987; 63 (6): 390-2
64. Gabriel G, Thin RN. Treatment of anogenital warts: comparison of trichloroacetic acid and podophyllin versus podophyllin alone. Br J Vener Dis 1983; 59 (2): 124-6
65. Montaldi DH, Giambrone JP, Courey NG, et al. Podophyllin poisoning associated with the treatment of condyloma acuminatum: a case report. Am J Obstet Gynecol 1974; 119 (8): 1130-1
66. von Krogh G, Longstaff E. Podophyllin office therapy against condyloma should be abandoned. Sex Transm Infect 2001; 77 (6): 409-12
67. Beutner KR. Podophyllotoxin in the treatment of genital warts. Curr Probl Dermatol 1996; 24: 227-32
68. Bashi SA. Cryotherapy versus podophyllin in the treatment of genital warts. Int J Dermatol 1985; 24 (8): 535-6
69. Longstaff E, von Krogh G. Condyloma eradication: self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations: an integrated safety assessment. Regul Toxicol Pharmacol 2001; 33 (2): 117-37
70. Lacey CJ, Goodall RL, Tennvall GR, et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003; 79 (4): 270-5
71. Centers for Disease Control and Prevention. Human papillomavirus infection: sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002; 51 (RR-6): 53-7
72. Kinghorn GR, McMillan A, Mulcahy F, et al. An open, comparative, study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllotoxin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS 1993; 4 (4): 194-9
73. Hellberg D, Svarrer T, Nilsson S, et al. Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution. Int J STD AIDS 1995; 6 (4): 257-61
74. Tyring S, Edwards L, Cherry LK, et al. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts. Arch Dermatol 1998; 134: 33-8
75. Wollina U. Er: YAG laser followed by topical podophyllotoxin for hard-to-treat palmoplantar warts. J Cosmet Laser Ther 2003; 5 (1): 35-7
76. Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ 2002; 325 (7362): 461
77. Buckley DA, Du Vivier AWP. The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol 2001; 145 (3): 385-405
78. Thomson S. The treatment of plantar warts with formalin. Br J Dermatol 1943; 55: 267-9
79. Amer M, Diab N, Ramadan A, et al. Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. J Am Acad Dermatol 1988; 18 (6): 1313-6
80. Shumer SM, O'Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 1983; 9 (1): 91-6
81. Munkvad M, Genner J, Staberg B, et al. Locally injected bleomycin in the treatment of warts. Dermatologica 1983; 167 (2): 86-9
82. Bunney MH, Nolan MW, Buxton PK, et al. The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial. Br J Dermatol 1984; 111 (2): 197-207
83. Hayes ME, O'Keefe EJ. Reduced dose of bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 1986; 15: 1002-6
84. Strauss MJ, Khanna V, Koenig JD, et al. The cost of treating genital warts. Int J Dermatol 1996; 35 (5): 340-8
85. Langley PC, Tyring SK, Smith MH. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Manag Care 1999; 5 (1): 69-77
86. Alam M, Stiller M. Direct medical costs for surgical and medical treatment of condylomata acuminata. Arch Dermatol 2001; 137 (3): 337-41
87. Billingham RP, Lewis FG. Laser versus electrical cautery in the treatment of condylomata acuminata of the anus. Surg Gynecol Obstet 1982; 155 (6): 865-7
88. von Krogh G, Wikstrom A, Syrjanen K, et al. Anal and penile condylomas in HIV-negative and HIV-positive men: clinical, histological and virological characteristics correlated to therapeutic outcome. Acta Dermatol Venereol 1995; 75 (6): 470-4
89. Coremans G, Margaritis V, Snoeck R, et al. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata. Dis Colon Rectum 2003; 46 (8): 1103-8
90. Mohanty KC. The cost effectiveness of treatment of genital warts with podophyllotoxin. Int J STD AIDS 1994; 5: 253-6
91. Morrison GD, Willcox JR, Challenor R, et al. Electrocoagulation in intrameatal warts. Int J STD AIDS 1992; 3: 215-6
92. Ghosh AK. Cryosurgery of genital warts in cases in which podophyllin treatment failed or was contraindicated. Br J Vener Dis 1977; 53: 49-53
93. Gibbs NF. Anogenital papillomavirus infections in children. Curr Opin Pediatr 1998; 10 (4): 393-7
94. Moresi JM, Herbert CR, Cohen BA. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream. Pediatr Dermatol 2001; 18 (5): 448-50
95. Saiag P, Bourgault-Villada I, Pavlovic M, et al. Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy. AIDS 2002; 16 (10): 1438-40
96. Hagman JH, Bianchi L, Marulli GC, et al. Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus. Clin Exp Dermatol 2003; 28 (3): 260-1
97. Gilson RJ, Shupack JL, Friedman-Kien AE, et al. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS 1999; 13 (17): 2397-404
98. Orlando G, Fasolo MM, Beretta R, et al. Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients. AIDS 2002; 16 (3): 447-50
99. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001; 20: 16-30
100. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the genitalia. Arch Dermatol 1979; 115: 306-8
101. Demeter LM, Stoler MH, Bonnez W, et al. Penile intraepithelial neoplasia: clinical presentation and an analysis of the physical state of HPV DNA. J Infect Dis 1993; 168 (1): 38-46
102. Jebakumar S, Bhattacharyya MN. Vulval intraepithelial neoplasia. Int J STD AIDS 1996; 7: 10-3
103. Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis. Arch Dermatol 1985; 121 (7): 858-63
104. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of HPV associated with cervical cancer. N Engl J Med 2003; 348 (6): 518-26
105. Tyring SK. Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol 2000; 43 (1 Suppl. 18-26)
106. Bleeker MC, Hogewoning CJ, Van den Brule AJ, et al. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002; 47 (3): 351-7
107. Palefsky JM, Barrasso R. HPV infection and disease in men. Obstet Gynecol Clin North Am 1996; 23 (4): 895-916
108. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia: specific clinical features correlate with histologic and virologic findings. Cancer 1994; 74 (6): 1762-7
109. Pow-Sang MR, Benavente V, Pow-Sang JE, et al. Cancer of the penis. Cancer Control 2002; 9 (4): 305-14
110. Joura EA, Losch A, Haider-Angeler MG, et al. Trends in vulvar neoplasia: increasing incidence of vulvar intraepithelial neoplasia and squamous carcinoma of the vulva in young women. J Reprod Med 2000; 45 (8): 613-5
111. Jones RW. The natural history of vulvar intraepithelial neoplasia. Br J Obstet Gynaecol 1995; 102: 764-6
112. Jay N, Berry JM, Hogeboom CJ, et al. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40 (8): 919-28
113. Zbar AP, Fenger C, Efron J, et al. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulval intraepithelial carcinoma. Int J Colorectal Dis 2002; 17: 203-15
114. Kadish AS. Biology of anogenital neoplasia. Cancer Treat Res 2001; 104: 267-86
115. Frisch M, Glimelius B, van den Brule AJC, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337 (19): 1350-7
116. Daling JR, Weiss NS, Klopfenstein LL, et al. Correlates of homosexual behaviour and the incidence of anal cancer. JAMA 1982; 247 (14): 1988-90
117. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV positive and HIV negative homosexual and bisexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17 (4): 320-6
118. Frisch M, Melbye M, Moller H. Trends in the incidence of anal cancer in Denmark. BMJ 1993; 306: 419-22
119. Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999; 59 (3): 753-7
120. Bower M, Powles T, Newsom-Davis T, et al. HIV associated anal cancer: has HAART reduced the incidence or improved the outcome? J AIDS 2004; 37 (5): 1563-5
121. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138 (6): 453-9
122. Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281 (19): 1822-9
123. Fox P, Stebbing J, Portsmouth S, et al. Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy. AIDS 2003; 17 (2): 279-80
124. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J AIDS 2001; 28 (5): 422-8
125. Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 1998; 52 (4): 559-65
126. Herod JJ, Shafi MI, Rollason TP, et al. Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women. Br J Obstet Gynaecol 1996; 103 (5): 446-52
127. Chang GJ, Berry JM, Jay N, et al. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002; 45 (4): 453-8
128. Krupp PJ, Bohm JW. 5-Fluorouracil topical treatment of in situ vulval cancer. Obstet Gynecol 1978; 51 (6): 702-6
129. Lifshitz S, Roberts JA. Treatment of carcinoma in situ with topical 5-fluorouracil. Obstet Gynecol 1980; 56 (2): 242-4
130. Cardamakis E, Relakis K, Ginopoulos P, et al. Treatment of penile intraepithelial neoplasia with interferon-2a, CO2 laser and 5-fluorouracil. Eur J Gynaecol Oncol 1997; 18 (5): 410-3
131. Todd RW, Etherington IJ, Luesley DM. The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecol Oncol 2002; 85 (1): 67-70
132. Kaspari M, Gutzmer R, Kiehl P, et al. Imiquimod 5% cream in the treatment of human papillomavirus 16 positive erythroplasia of Queyrat. Dermatology 2002; 205 (1): 67-9
133. Schroeder TL, Sengelman RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002; 46 (4): 545-8
134. Descamps V, Duval X, Grossih M, et al. Topical cidofovir for bowenoid papulosis in an HIV infected patient. Br J Dermatol 2001; 144 (3): 642-3
135. Calista D. Topical cidofovir for erythroplasia of Queyrat of the glans penis. Br J Dermatol 2002; 147: 399-400
136. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a HPV type 16 vaccine. N Engl J Med 2002; 347 (21): 1645-51